首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   36篇
  免费   1篇
基础医学   5篇
口腔科学   2篇
临床医学   1篇
内科学   16篇
神经病学   2篇
特种医学   1篇
外科学   2篇
预防医学   6篇
药学   2篇
  2023年   1篇
  2022年   1篇
  2021年   2篇
  2020年   3篇
  2019年   4篇
  2018年   2篇
  2017年   5篇
  2016年   2篇
  2015年   2篇
  2014年   1篇
  2013年   2篇
  2012年   2篇
  2011年   1篇
  2010年   2篇
  2009年   1篇
  2005年   2篇
  2000年   1篇
  1994年   1篇
  1986年   1篇
  1978年   1篇
排序方式: 共有37条查询结果,搜索用时 15 毫秒
1.
来用锁相环IC CD4046设计的心率显示报警电路,用于数台老式监护仪的改造中,获得成功.  相似文献   
2.

Background

In the Southern Hemisphere 2010 influenza season, Seqirus’ split-virion, trivalent inactivated influenza vaccine was associated with increased reports of fevers and febrile reactions in young children. A staged clinical development program of a quadrivalent vaccine (Seqirus IIV4 [S-IIV4]; Afluria® Quadrivalent/Afluria Quad?/Afluria Tetra?), wherein each vaccine strain is split using a higher detergent concentration to reduce lipid content (considered the cause of the increased fevers and febrile reactions), is now complete.

Methods

Children aged 6–59?months were randomized 3:1 and stratified by age (6–35?months/36–59?months) to receive S-IIV4 (n?=?1684) or a United States (US)-licensed comparator IIV4 (C-IIV4; Fluzone® Quadrivalent; n?=?563) during the Northern Hemisphere 2016–2017 influenza season. The primary objective was to demonstrate noninferior immunogenicity of S-IIV4 versus C-IIV4. Immunogenicity was assessed by hemagglutination inhibition (baseline, 28?days postvaccination). Solicited, unsolicited, and serious adverse events were assessed for 7, 28, and 180?days postvaccination, respectively.

Results

S-IIV4 met the immunogenicity criteria for noninferiority. Adjusted geometric mean titer ratios (C-IIV4/S-IIV4) for the A/H1N1, A/H3N2, B/Yamagata, and B/Victoria strains were 0.79 (95% CI: 0.72, 0.88), 1.27 (1.15, 1.42), 1.12 (1.01, 1.24), and 0.97 (0.86, 1.09), respectively. Corresponding values for differences in seroconversion rates (C-IIV4 minus S-IIV4) were ?10.3 (?15.4, ?5.1), 2.6 (?2.5, 7.8), 3.1 (?2.1, 8.2), and 0.9 (?4.2, 6.1). Solicited, unsolicited, and serious adverse events were similar between vaccines in both age cohorts, apart from fever. Fever rates were lower with S-IIV4 (5.8%) than C-IIV4 (8.4%), with no febrile convulsions reported with either vaccine during the 7?days postvaccination.

Conclusion

S-IIV4, manufactured with a higher detergent concentration, demonstrated noninferior immunogenicity to the US-licensed C-IIV4, with similar postvaccination safety and tolerability, in children aged 6–59?months. This completes the program demonstrating the immunogenicity and safety of S-IIV4 in participants aged 6?months and older.

Funding

Seqirus Pty Ltd; ClinicalTrials.gov identifier:NCT02914275.  相似文献   
3.
4.
5.
The aim was to evaluate the design parameters of dental implants shape, diameter and length on stress distribution by finite element analysis (FEA).The objectives of the study was to compare the influence of stress distribution in the implants of screw-vent tapered and parallel design by varying the implant diameter with a standard implant length. Six dental implant models have been simulated three-dimensionally. The influence of diameter and length on stress distribution was evaluated by Group I: for screw-vent tapered design (Zimmer Dental Implant Carlsbad, CA, USA) (1) Dental implant model with diameter 3.7 mm and length 13 mm. (2) Dental implant model with diameter 4.1 mm and length 13 mm. (3) Dental implant model with diameter 4.7 mm and length 13 mm. Group II: for parallel design (Zimmer Dental Implant Carlsbad, CA, USA) (4) Dental implant model with diameter 3.7 mm and length 13 mm. (5) Dental implant model with diameter 4.1 mm and length 13 mm. (6) Dental implant model with diameter 4.7 mm and length 13 mm. The 3-D model of the implant was created in the pro-e wildfire 4.0 software by giving various commands. This model was imported to the ANSYS software through IGES (initial graphic exchange specification) file for further analysis. All six models were loaded with a force of 17.1, 114.6 and 23.4 N in a lingual, an axial and disto-mesial direction respectively, simulating average masticatory force in a natural oblique direction, to analyze the stress distribution on these implants. The increase in implant diameter in Group I and Group II from 3.7 to 4.1 mm and from 4.1 to 4.7 mm with constant 13 mm length for screw-vent tapered and parallel design implant resulted in a reduction in maximum value of Von Mises stress in the bone surrounding the implant was statistically significant at 5% level done by student “t” test. The overall maximum value of Von Mises stress was decreased in parallel design implant diameter of 4.7 mm with constant length of 13 mm when compared to screw-vent tapered design implant samples. The results of the FEA computation depend on many individual factors including material properties, boundary conditions interface definition and also on the overall approach to the model. The results depicted that the tapered shape implant design exhibited higher stress levels in bone than the parallel shaped implant design which seemed to be distributing stresses more evenly. The application of a 3-D model simulation with the non-symmetric loading by the masticatory force on a dental implant resulted in a more satisfactory modeling of “clinical reality” than that achieved with 2-D models used in other studies.  相似文献   
6.
用牙科发声探针测量牙齿根管长度,操作简便,准确度高.本文介绍了YⅡ型牙科发声探针的设计原理及工作过程,并给出了整机的电路原理图.  相似文献   
7.
The Strategic Group of Advisory Experts (SAGE) on immunization is an independent advisory committee with a mandate to advise the World Health Organization (WHO) on the development of vaccine and immunization related policies. SAGE working groups are established on a time-limited basis to review and provide evidence-based recommendations, together with their implications, for open deliberation and decision-making by SAGE. In making its recommendations, SAGE takes into consideration: the epidemiologic and clinical characteristics of the disease; vaccine and immunization characteristics; economic analysis; health system considerations; the existence of and interaction with other intervention and control strategies; costing and social impacts; and legal and ethical concerns. Since 1998, WHO has produced evidence-based vaccine position papers for use primarily by national public health officials and immunization programme managers. Since April 2006 all new or updated position papers have been based on SAGE recommendations. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach has been adopted by WHO and, since 2008, GRADE tables that rate the quality of evidence have been produced in support of key recommendations. SAGE previously expressed concern that GRADE was not ideally suited to many immunization-specific issues such as the vaccine population level effect and the inclusion of surveillance system data, particularly for vaccine safety. Extensive productive interactions with various advisory groups including the US Advisory Committee on Immunization Practices, the European Centres for Disease Control, the German Standing Committee on Vaccination (STIKO), WHO's Global Advisory Committee on Vaccine Safety and the GRADE working group resulted in key enhancements to accommodate vaccine-relevant evidence. This facilitated integration and acceptability of the GRADE approach in the development of immunization related SAGE and WHO recommendations. Ongoing utilisation should result in further fine-tuning of the approach to ensure that recommendations are based on the full range of appropriate evidence.  相似文献   
8.
《Value in health》2015,18(8):1138-1151
ObjectivesTo systematically review the choice of comparator strategies in cost-effectiveness analyses (CEAs) of human papillomavirus testing in cervical screening.MethodsThe PubMed, Web of Knowledge, and Scopus databases were searched to identify eligible model-based CEAs of cervical screening programs using human papillomavirus testing. The eligible CEAs were reviewed to investigate what screening strategies were chosen for analysis and how this choice might have influenced estimates of the incremental cost-effectiveness ratio (ICER). Selected examples from the reviewed studies are presented to illustrate how the omission of relevant comparators might influence estimates of screening cost-effectiveness.ResultsThe search identified 30 eligible CEAs. The omission of relevant comparator strategies appears likely in 21 studies. The ICER estimates in these cases are probably lower than would be estimated had more comparators been included. Five of the 30 studies restricted relevant comparator strategies to sensitivity analyses or other subanalyses not part of the principal base-case analysis. Such exclusion of relevant strategies from the base-case analysis can result in cost-ineffective strategies being identified as cost-effective.ConclusionsMany of the CEAs reviewed appear to include insufficient comparator strategies. In particular, they omit strategies with relatively long screening intervals. Omitting relevant comparators matters particularly if it leads to the underestimation of ICERs for strategies around the cost-effectiveness threshold because these strategies are the most policy relevant from the CEA perspective. Consequently, such CEAs may not be providing the best possible policy guidance and lead to the mistaken adoption of cost-ineffective screening strategies.  相似文献   
9.
The six major questions of attention are described in terms of the dominant, as defined by Ukhtomskii. The dominant was in turn simulated as a systems manifestation of phase transitions in the brain. The theoretical and experimental bases for the existence of metastable states in the brain are reviewed, these states having lifetimes of 1 sec and more. This approach simultaneously provides solutions for all the major questions of attention and the central controller. A neurobiological model of attention and memory is proposed, based on the systems properties of Ukhtomskiis dominant and the comparator function of the hippocampus as described by Vinogradova. New published data are presented to support the existence of an information processing system in the brain in which the hippocampus plays the central role.Translated from Zhurnal Vysshei Nervnoi Deyatelnosti, Vol. 54, No. 1, pp. 11–31, January–February, 2004.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号